NR 601 Week 6 Test Bank: Metformin, Sglt2 Inhibitors And Ascvd Management Questions

Gain immediate exam readiness by mastering the clinical nuances of diabetes management covered in NR 601 Week 6. This resource provides precise, A+ graded responses to high-yield questions regarding Metformin usage, specifically addressing gastrointestinal side effects, Vitamin B12 deficiency risks, and renal function thresholds for safe administration. Learners will enhance their understanding of adjunctive therapies for atherosclerotic cardiovascular disease (ASCVD), including the specific indications for Canagliflozin and Empagliflozin. By reviewing these targeted questions and answers, students can refine their clinical decision-making skills and ensure comprehensive coverage of key pharmacological concepts required for assessment success.

This document is designed for nursing students enrolled in the NR 601 course who are preparing for week six assessments. It serves as a vital revision tool for candidates seeking to verify their understanding of diabetic medication protocols and patient safety criteria. Tutors and educators may also use these graded answers to benchmark student performance or clarify complex pharmacological distinctions.